These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3889721)

  • 1. [Experimental study on the use of cisplatin in oncology].
    Scanni A; Tomirotti M; Campolunghi D; Biraghi M; Curtarelli G
    Minerva Med; 1985 Apr; 76(17-18):851-7. PubMed ID: 3889721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
    Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
    Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cis-platinum in solid-tumor therapy.
    Einhorn LH; Williams SD
    N Engl J Med; 1979 Feb; 300(6):289-91. PubMed ID: 366407
    [No Abstract]   [Full Text] [Related]  

  • 5. cis-Dichlorodiamminepltinum(II) in adult patients: Southwest Oncology Group Studies.
    Stephens R; Coltman C; Rossof A; Samson M; Panettiere F; Al-Sarraf M; Alberts D; Bonnet J
    Cancer Treat Rep; 1979; 63(9-10):1609-10. PubMed ID: 498160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis-platinum in the treatment of testicular and other cancers.
    Williams SD; Einhorn LH
    Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study.
    Kish JA; Benedetti JK; Balcerzak SP; Veith RW; Davis R; Pollock TW; Schuller DE; Ensley JF
    Cancer J Sci Am; 1999; 5(5):307-11. PubMed ID: 10526672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cisplatin and cyclosporin A in recurrent platinum-resistant ovarian cancer: a phase II study of the gynecologic oncology group.
    Manetta A; Blessing JA; Hurteau JA
    Gynecol Oncol; 1998 Jan; 68(1):45-6. PubMed ID: 9454659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of advanced ovarian cancer.
    Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
    Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.
    Kish J; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh J; Weaver A; Al-Sarraf M
    Cancer Treat Rep; 1982 Mar; 66(3):471-4. PubMed ID: 7037180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epithelial neoplasms of the head and neck. Study of 72 cases treated with radiotherapy only or combined with chemotherapy].
    Boidi Trotti A; Burke P; Tardy A
    Arch Sci Med (Torino); 1979; 136(2):275-8. PubMed ID: 518280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cisplatinum compounds].
    Ota K
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):50-8. PubMed ID: 8380687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
    Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
    Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective outpatient combination chemotherapy for advanced cancer of the head and neck.
    Chiuten D; Vogl SE; Kaplan BH; Greenwald E
    Surg Gynecol Obstet; 1980 Nov; 151(5):659-62. PubMed ID: 6159692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II-III- study of cis-diaminodichloroplatinum (cisplatinum) (author's transl)].
    Cortés-Funes H; Moyano A
    Med Clin (Barc); 1981 May; 76(9):388-95. PubMed ID: 7017298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.